Carta Acesso aberto Revisado por pares

Alzheimer's disease and glaucoma: Look‐alike neurodegenerative diseases

2019; Wiley; Volume: 15; Issue: 4 Linguagem: Inglês

10.1016/j.jalz.2018.12.012

ISSN

1552-5279

Autores

Peter Wostyn, Debby Van Dam, Peter Paul De Deyn,

Tópico(s)

Retinal Imaging and Analysis

Resumo

Alzheimer's & DementiaVolume 15, Issue 4 p. 600-601 Letter Alzheimer's disease and glaucoma: Look-alike neurodegenerative diseases Peter Wostyn, Corresponding Author Peter Wostyn wostyn.peter@skynet.be +32-472713719 | Fax: +32-50-819720 Department of Psychiatry, PC Sint-Amandus, Beernem, Belgium Corresponding author. Tel.: +32-472713719; Fax: +32-50-819720. E-mail address: wostyn.peter@skynet.beSearch for more papers by this authorDebby Van Dam, Debby Van Dam Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Department of Biomedical Sciences, Antwerp, Belgium Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen, Groningen, The NetherlandsSearch for more papers by this authorPeter Paul De Deyn, Peter Paul De Deyn Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Department of Biomedical Sciences, Antwerp, Belgium Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands Department of Neurology and Memory Clinic, Middelheim General Hospital (ZNA), Antwerp, BelgiumSearch for more papers by this author Peter Wostyn, Corresponding Author Peter Wostyn wostyn.peter@skynet.be +32-472713719 | Fax: +32-50-819720 Department of Psychiatry, PC Sint-Amandus, Beernem, Belgium Corresponding author. Tel.: +32-472713719; Fax: +32-50-819720. E-mail address: wostyn.peter@skynet.beSearch for more papers by this authorDebby Van Dam, Debby Van Dam Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Department of Biomedical Sciences, Antwerp, Belgium Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen, Groningen, The NetherlandsSearch for more papers by this authorPeter Paul De Deyn, Peter Paul De Deyn Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Department of Biomedical Sciences, Antwerp, Belgium Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands Department of Neurology and Memory Clinic, Middelheim General Hospital (ZNA), Antwerp, BelgiumSearch for more papers by this author First published: 31 January 2019 https://doi.org/10.1016/j.jalz.2018.12.012Citations: 1 Financial Support: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Declaration of interest: Dr. Peter Wostyn is the inventor of pending patent applications pertaining to glaucoma and Alzheimer's disease treatment using an intrathecal cerebrospinal fluid pump system, filed by P&X Medical NV. The other authors declare no conflicts of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume15, Issue4April 2019Pages 600-601 RelatedInformation

Referência(s)